Pyrimidine, triazine and pyrazine derivatives as glutamate receptors

Details for Australian Patent Application No. 2002319183 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Binggeli, Alfred; Wilhelm, Maurice; Mutel, Vincent; Maerki, Hans-Peter; Wostl, Wolfgang; Masquelin, Thierry

Agent Spruson & Ferguson

Pub. Number AU-B-2002319183

PCT Number PCT/EP02/05788

PCT Pub. Number WO2002/098864

Priority 01113379.0 01.06.01 EP

Filing date 27 May 2002

Wipo publication date 16 December 2002

Acceptance publication date 10 May 2007

International Classifications

C07D 253/06 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/12 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 01113379.0 01.06.01 EP

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002319183

10 May 2007 Application Accepted

  Published as AU-B-2002319183

6 September 2007 Standard Patent Sealed

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319184-Bake type aromatising compositions

2002319182-PROBE ARRANGEMENT